Why did MED.SW stock rally today?

MED.SW stock rose **6.42%** on 17 Mar 2026 due to a company update and stronger intraday buying. Positive attention to cash per share **CHF9.97** and above-average volume **4,788.00** supported the rally. Short-term traders drove the top-gainer move on SIX

What are key valuation metrics for MED.SW stock?

Key metrics: price **CHF84.60**, P/S **4.40**, P/B **3.87**, EPS **-0.05**, and EV/EBITDA **29.47**. Price-to-earnings is negative. These metrics show a mixed valuation with strong balance-sheet ratios but a negative EPS

What does Meyka AI forecast for MED.SW stock?

Meyka AI's forecast model projects a yearly level of **CHF83.63** and a quarterly projection of **CHF98.37**. Versus the last price **CHF84.60**, that implies **-1.17%** and **+16.27%**, respectively. Forecasts are model-based and not guarantees

What are the main risks for MED.SW stock?

Top risks include negative EPS, long inventory days (**641.96**), and margin pressure. Valuation metrics such as EV/EBITDA **29.47** increase sensitivity to sales weakness. Sector demand shifts would affect medical-device revenue and MED.SW stock performance

CH Stocks

Medartis (MED.SW) up 6.42% on SIX 17 Mar 2026: price targets and outlook

ByHuzaifa Zahoor March 18, 2026

MED.SW stock closed the Swiss session at CHF84.60, up 6.42% on SIX on 17 Mar 2026 after a market-moving update. Volume reached 4,788.00, above the 50-day average, and the intraday range was CHF82.00–85.80. The rally places Medartis Holding AG in the top gainers on the Swiss market today. We examine the drivers behind the move, the company’s financials, key ratios, technical set-up and what Meyka AI’s forecast implies for traders and investors.